BIORASIS Inc. , was established in Dec. 2007 with an initial goal to commercialize UCONN’s and OSCI’s wireless, needle-implantable, miniaturized (0.5 x 0.5 x 5 mm) sensor platform for real time, continuous glucose monitoring.
In addition to glucose monitoring Biorasis is working towards outfitting its sensor platform to monitor other bio-analytes in the body that are important in other disorders such as cardiovascular, cancer, liver, kidney abnormalities, stroke and epilepsy.
BIORASIS Inc. mission is to provide high quality wireless implantable bio-analyte sensors that combine high performance and accuracy with value pricing, in order to meet and exceed our customer needs and expectations, while establishing a successful relationship with our partners.